Clinical Trial Update: Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pazopanib hydrochloride combined with topotecan hydrochloride in adults with metastatic or recurrent soft tissue and bone sarcomas; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liposarcoma
• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib hydrochloride (pazopanib)
• Topotecan hydrochloride (topotecan hydrochloride)

Snippet

Sponsor: Northwestern University | Conditions: Adult Liposarcoma, Metastatic Liposarcoma | Phase 2 | Status: COMPLETED | Results posted: 2020-08-10